<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; multiplier</title>
	<atom:link href="http://www.tapanray.in/tag/multiplier/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Are Pharma Business Ethics And Performance Interlinked?</title>
		<link>http://www.tapanray.in/are-pharma-business-ethics-and-performance-interlinked/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-pharma-business-ethics-and-performance-interlinked</link>
		<comments>http://www.tapanray.in/are-pharma-business-ethics-and-performance-interlinked/#comments</comments>
		<pubDate>Mon, 11 Nov 2019 00:00:48 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[behavior]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[consumer]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[economic]]></category>
		<category><![CDATA[ethical]]></category>
		<category><![CDATA[Ethics]]></category>
		<category><![CDATA[expect]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Interlinked]]></category>
		<category><![CDATA[multiplier]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[perception]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reputation]]></category>
		<category><![CDATA[systemic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9768</guid>
		<description><![CDATA[Way back in the 1960s, many could realize that of upcoming consumer-focused business environment will bring business practices under intense stakeholder scrutiny. This prompted both the business schools, as well as the commercial organizations to bring the concept of ‘business &#8230; <a href="http://www.tapanray.in/are-pharma-business-ethics-and-performance-interlinked/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/are-pharma-business-ethics-and-performance-interlinked/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Force Multiplier: An &#8220;Armageddon&#8221;: A Contender for Supremacy in the Generic Pharma World</title>
		<link>http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world</link>
		<comments>http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/#comments</comments>
		<pubDate>Mon, 22 Apr 2013 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ANDAa]]></category>
		<category><![CDATA[API]]></category>
		<category><![CDATA[Armageddon]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[BRIC]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[contender]]></category>
		<category><![CDATA[defend]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Developing]]></category>
		<category><![CDATA[DMFs]]></category>
		<category><![CDATA[DRL]]></category>
		<category><![CDATA[EU]]></category>
		<category><![CDATA[factor]]></category>
		<category><![CDATA[fastest]]></category>
		<category><![CDATA[force]]></category>
		<category><![CDATA[Frost&Sullivan]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[Glenmark]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[Guardian]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infringing]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[multiplier]]></category>
		<category><![CDATA[NCE]]></category>
		<category><![CDATA[Non]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[perception]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Sun]]></category>
		<category><![CDATA[supremacy]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Taro]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[triggering]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[UK-MHRA]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[USFDA]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[World]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2193</guid>
		<description><![CDATA[It is very important for any country to ensure access to most appropriate medicines for the patients as and when they require. In many disease areas such access can be remarkably improved through affordable generic drugs, which offer significant savings &#8230; <a href="http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
